Status:
UNKNOWN
The PerX360º System™ Registry
Lead Sponsor:
Interventional Spine, Inc.
Conditions:
DDD
Eligibility:
All Genders
18+ years
Brief Summary
This is a multi-center, non-randomized post marketing surveillance registry including up to 125 patients treated with the PerX360º System™. Patients will receive a follow-up evaluation at the per phys...
Detailed Description
For all patients participating in the registry, the following outcomes will be analyzed: * Change in pain score on the Visual Analog Scale(VAS) from baseline for leg pain * Change in pain score on th...
Eligibility Criteria
Inclusion
- Patient understands the nature of the procedure and provides written informed consent
- Patient is willing to return to the treating physician for his/her routine follow-up visits up to 12 months post treatment
- Age \> 18 years
- Patient is treated with the Optiport™ and Opticage™ products
Exclusion
- None
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2013
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT01796535
Start Date
November 1 2012
End Date
June 1 2013
Last Update
March 15 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles Brain and Spine Institute
Los Angeles, California, United States, 90036
2
Flagler Hospital
Saint Augustine, Florida, United States, 32086